Abbreviation: INH
A prodrug activated by bacterial catalase-peroxidase. It inhibits mycolic acid synthesis, which is a vital component of mycobacterial cell walls. Mainly used in treatment and prophylaxis of tuberculosis. It is a P450 cytochrome inhibitor with many drug-drug interactions.